サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1347977

植物性医薬品の世界市場の考察、予測（～2029年）

Global Botanical Drug Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
植物性医薬品の世界市場の考察、予測（～2029年）
出版日: 2023年09月15日
発行: QYResearch
ページ情報: 英文 145 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の植物性医薬品の市場規模は、2023年に381億6,400万米ドル、2029年までに504億9,960万米ドルに達し、予測期間中にCAGRで4.78%の成長が予測されています。

北米市場は、2023年に16億8,240万米ドル、2029年までに23億4,200万米ドルに達し、2024年～2029年の予測期間中にCAGRで5.67%の成長が予測されています。

中国市場は、2023年に222億1,200万米ドル、2029年までに287億9,600万米ドルに達し、予測期間中のCAGRは4.42%です。

欧州市場は、2023年に66億5,000万米ドル、2029年までに92億2,900万米ドルに達し、予測期間中のCAGRは5.61％です。

当レポートでは、世界の植物性医薬品市場について調査分析し、市場規模と予測、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 レポートの概要

  • 調査の範囲
  • 市場の分析：タイプ別
    • 世界の植物性医薬品の市場規模成長率：タイプ別（2018年・2022年・2029年）
    • 処方薬
    • OTC
  • 市場：用途別
    • 世界の植物性医薬品の市場シェア：用途別（2018年・2022年・2029年）
    • 心血管
    • 腫瘍
    • 呼吸器系
  • 前提条件と制限
  • 調査目的
  • 考慮された年数

第2章 世界の成長動向

  • 世界の植物性医薬品市場の見通し（2018年～2029年）
  • 世界の植物性医薬品の成長動向：地域別
    • 世界の植物性医薬品の市場規模：地域別（2018年・2022年・2029年）
    • 植物性医薬品の市場規模の実績：地域別（2018年～2023年）
    • 植物性医薬品の市場規模の予測：地域別（2024年～2029年）
  • 植物性医薬品の市場力学
    • 植物性医薬品産業の動向
    • 植物性医薬品市場の促進要因
    • 植物性医薬品市場の課題
    • 植物性医薬品市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の植物性医薬品の収益：企業別
    • 世界の植物性医薬品の収益：企業別（2019年～2023年）
    • 世界の植物性医薬品の収益の市場シェア：企業別（2019年～2023年）
  • 世界の植物性医薬品市場：企業タイプ別（Tier 1・Tier 2・Tier 3）
  • 世界の植物性医薬品の主要企業、収益ランキング（2021年・2022年）
  • 世界の植物性医薬品の市場集中度
    • 世界の植物性医薬品の市場集中度比（CR5とHHI）
    • 世界の植物性医薬品の収益の上位10社、上位5社（2022年）
  • 世界の植物性医薬品の主要企業の本社、サービス地域
  • 世界の植物性医薬品の主要企業、設立日
  • 合併と買収、拡張計画

第4章 植物性医薬品の内訳データ：タイプ別

  • 世界の植物性医薬品の市場規模の実績：タイプ別（2018年～2023年）
  • 世界の植物性医薬品の市場規模の予測：タイプ別（2024年～2029年）

第5章 植物性医薬品の内訳データ：用途別

  • 世界の植物性医薬品の市場規模の実績：用途別（2018年～2023年）
  • 世界の植物性医薬品の市場規模の予測：用途別（2024年～2029年）

第6章 北米

  • 北米の植物性医薬品の市場規模（2018年～2029年）
  • 北米の植物性医薬品の市場規模：タイプ別
    • 北米の植物性医薬品の市場規模：タイプ別（2018年～2023年）
    • 北米の植物性医薬品の市場規模：タイプ別（2024年～2029年）
    • 北米の植物性医薬品の市場シェア：タイプ別（2018年～2029年）
  • 北米の植物性医薬品の市場規模：用途別
    • 北米の植物性医薬品の市場規模：用途別（2018年～2023年）
    • 北米の植物性医薬品の市場規模：用途別（2024年～2029年）
    • 北米の植物性医薬品の市場シェア：用途別（2018年～2029年）
  • 北米の植物性医薬品の市場規模：国別
    • 北米の植物性医薬品の市場規模：国別（2018年・2022年・2029年）
    • 北米の植物性医薬品の市場規模：国別（2018年～2023年）
    • 北米の植物性医薬品の市場シェア：国別（2024年～2029年）
    • 米国
    • カナダ

第7章 欧州

  • 欧州の植物性医薬品の市場規模（2018年～2029年）
  • 欧州の植物性医薬品の市場規模：タイプ別
    • 欧州の植物性医薬品の市場規模：タイプ別（2018年～2023年）
    • 欧州の植物性医薬品の市場規模：タイプ別（2024年～2029年）
    • 欧州の植物性医薬品の市場シェア：タイプ別（2018年～2029年）
  • 欧州の植物性医薬品の市場規模：用途別
    • 欧州の植物性医薬品の市場規模：用途別（2018年～2023年）
    • 欧州の植物性医薬品の市場規模：用途別（2024年～2029年）
    • 欧州の植物性医薬品の市場シェア：用途別（2018年～2029年）
  • 欧州の植物性医薬品の市場規模：国別
    • 欧州の植物性医薬品の市場規模：国別（2018年・2022年・2029年）
    • 欧州の植物性医薬品の市場規模：国別（2018年～2023年）
    • 欧州の植物性医薬品の市場規模：国別（2024年～2029年）
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の植物性医薬品の市場規模（2018年～2029年）
  • 中国の植物性医薬品の市場規模：タイプ別
    • 中国の植物性医薬品の市場規模：タイプ別（2018年～2023年）
    • 中国の植物性医薬品の市場規模：タイプ別（2024年～2029年）
    • 中国の植物性医薬品の市場シェア：タイプ別（2018年～2029年）
  • 中国の植物性医薬品の市場規模：用途別
    • 中国の植物性医薬品の市場規模：用途別（2018年～2023年）
    • 中国の植物性医薬品の市場規模：用途別（2024年～2029年）
    • 中国の植物性医薬品の市場シェア：用途別（2018年～2029年）

第9章 アジア（中国を除く）

  • アジアの植物性医薬品の市場規模（2018年～2029年）
  • アジアの植物性医薬品の市場規模：タイプ別
    • アジアの植物性医薬品の市場規模：タイプ別（2018年～2023年）
    • アジアの植物性医薬品の市場規模：タイプ別（2024年～2029年）
    • アジアの植物性医薬品の市場シェア：タイプ別（2018年～2029年）
  • アジアの植物性医薬品の市場規模：用途別
    • アジアの植物性医薬品の市場規模：用途別（2018年～2023年）
    • アジアの植物性医薬品の市場規模：用途別（2024年～2029年）
    • アジアの植物性医薬品の市場シェア：用途別（2018年～2029年）
  • アジアの植物性医薬品の市場規模：地域別
    • アジアの植物性医薬品の市場規模：地域別（2018年・2022年・2029年）
    • アジアの植物性医薬品の市場規模：地域別（2018年～2023年）
    • アジアの植物性医薬品の市場規模：地域別（2024年～2029年）
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東・アフリカ・ラテンアメリカ

  • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模（2018年～2029年）
  • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：タイプ別
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：タイプ別（2018年～2023年）
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：タイプ別（2024年～2029年）
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場シェア：タイプ別（2018年～2029年）
  • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：用途別
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：用途別（2018年～2023年）
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：用途別（2024年～2029年）
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場シェア：用途別（2018年～2029年）
  • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：国別
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：国別（2018年・2022年・2029年）
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：国別（2018年～2023年）
    • 中東・アフリカ・ラテンアメリカの植物性医薬品の市場規模：国別（2024年～2029年）
    • ブラジル
    • メキシコ
    • 中東
    • アフリカ

第11章 主要企業のプロファイル

  • Buchang Pharmaceuticals
  • China TCM
  • Tsumura
  • Schwabe
  • Tong Ren Tang
  • Jumpcan Pharmaceutical
  • Guangzhou Baiyunshan Pharmaceutical
  • Yunnan Baiyao
  • Tasly Holding Group
  • Bionorica Se
  • Huarun
  • Taiji
  • Weleda
  • Kwangdong
  • GW Pharmaceuticals

第12章 アナリストの視点/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Botanical Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Global Botanical Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 3. Global Botanical Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 4. Global Botanical Drug Market Size by Region (2018-2023) & (US$ Million)
  • Table 5. Global Botanical Drug Market Share by Region (2018-2023)
  • Table 6. Global Botanical Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 7. Global Botanical Drug Market Share by Region (2024-2029)
  • Table 8. Botanical Drug Market Trends
  • Table 9. Botanical Drug Market Drivers
  • Table 10. Botanical Drug Market Challenges
  • Table 11. Botanical Drug Market Restraints
  • Table 12. Global Botanical Drug Revenue by Players (2019-2023) & (US$ Million)
  • Table 13. Global Botanical Drug Market Share by Players (2019-2023)
  • Table 14. Global Top Botanical Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2021)
  • Table 15. Global Botanical Drug Industry Ranking 2021 VS 2022
  • Table 16. Global 5 Largest Players Market Share by Botanical Drug Revenue (CR5 and HHI) & (2019-2023)
  • Table 17. Global Key Players of Botanical Drug, Headquarters and Area Served
  • Table 18. Global Key Players of Botanical Drug, Founded Date
  • Table 19. Mergers & Acquisitions, Expansion Plans
  • Table 20. Global Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 21. Global Botanical Drug Revenue Market Share by Type (2018-2023)
  • Table 22. Global Botanical Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 23. Global Botanical Drug Revenue Market Share by Type (2024-2029)
  • Table 24. Global Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 25. Global Botanical Drug Revenue Market Share by Application (2018-2023)
  • Table 26. Global Botanical Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 27. Global Botanical Drug Revenue Market Share by Application (2024-2029)
  • Table 28. North America Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 29. North America Botanical Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 30. North America Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 31. North America Botanical Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 32. North America Botanical Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 33. North America Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
  • Table 34. North America Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
  • Table 35. Europe Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 36. Europe Botanical Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 37. Europe Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 38. Europe Botanical Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 39. Europe Botanical Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 40. Europe Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
  • Table 41. Europe Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
  • Table 42. China Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 43. China Botanical Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 44. China Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 45. China Botanical Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 46. Asia Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. Asia Botanical Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. Asia Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. Asia Botanical Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Botanical Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 51. Asia Botanical Drug Market Size by Region (2018-2023) & (US$ Million)
  • Table 52. Asia Botanical Drug Market Size by Region (2024-2029) & (US$ Million)
  • Table 53. Middle East, Africa, and Latin America Botanical Drug Market Size by Type (2018-2023) & (US$ Million)
  • Table 54. Middle East, Africa, and Latin America Botanical Drug Market Size by Type (2024-2029) & (US$ Million)
  • Table 55. Middle East, Africa, and Latin America Botanical Drug Market Size by Application (2018-2023) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Botanical Drug Market Size by Application (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Botanical Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 58. Middle East, Africa, and Latin America Botanical Drug Market Size by Country (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Botanical Drug Market Size by Country (2024-2029) & (US$ Million)
  • Table 60. Buchang Pharmaceuticals Corporate Information
  • Table 61. Buchang Pharmaceuticals Major Business
  • Table 62. Buchang Pharmaceuticals Botanical Drug Product and Solutions
  • Table 63. Buchang Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 64. China TCM Corporate Information
  • Table 65. China TCM Major Business
  • Table 66. China TCM Botanical Drug Product and Solutions
  • Table 67. China TCM Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 68. Tsumura Corporate Information
  • Table 69. Tsumura Major Business
  • Table 70. Tsumura Botanical Drug Product and Solutions
  • Table 71. Tsumura Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 72. Schwabe Corporate Information
  • Table 73. Schwabe Major Business
  • Table 74. Schwabe Botanical Drug Product and Solutions
  • Table 75. Schwabe Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 76. Tong Ren Tang Corporate Information
  • Table 77. Tong Ren Tang Major Business
  • Table 78. Tong Ren Tang Botanical Drug Product and Solutions
  • Table 79. Tong Ren Tang Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 80. Jumpcan Pharmaceutical Corporate Information
  • Table 81. Jumpcan Pharmaceutical Major Business
  • Table 82. Jumpcan Pharmaceutical Botanical Drug Product and Solutions
  • Table 83. Jumpcan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 84. Guangzhou Baiyunshan Pharmaceutical Corporate Information
  • Table 85. Guangzhou Baiyunshan Pharmaceutical Major Business
  • Table 86. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
  • Table 87. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 88. Yunnan Baiyao Corporate Information
  • Table 89. Yunnan Baiyao Major Business
  • Table 90. Yunnan Baiyao Botanical Drug Product and Solutions
  • Table 91. Yunnan Baiyao Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 92. Tasly Holding Group Corporate Information
  • Table 93. Tasly Holding Group Major Business
  • Table 94. Tasly Holding Group Botanical Drug Product and Solutions
  • Table 95. Tasly Holding Group Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 96. Bionorica Se Corporate Information
  • Table 97. Bionorica Se Major Business
  • Table 98. Bionorica Se Botanical Drug Product and Solutions
  • Table 99. Bionorica Se Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 100. Huarun 999 Corporate Information
  • Table 101. Huarun 999 Major Business
  • Table 102. Huarun 999 Botanical Drug Product and Solutions
  • Table 103. Huarun 999 Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 104. Taiji Corporate Information
  • Table 105. Taiji Major Business
  • Table 106. Taiji Botanical Drug Product and Solutions
  • Table 107. Taiji Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 108. Weleda Corporate Information
  • Table 109. Weleda Major Business
  • Table 110. Weleda Botanical Drug Product and Solutions
  • Table 111. Weleda Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 112. Kwangdong Corporate Information
  • Table 113. Kwangdong Major Business
  • Table 114. Kwangdong Botanical Drug Product and Solutions
  • Table 115. Kwangdong Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 116. GW Pharmaceuticals Corporate Information
  • Table 117. GW Pharmaceuticals Major Business
  • Table 118. GW Pharmaceuticals Botanical Drug Product and Solutions
  • Table 119. GW Pharmaceuticals Botanical Drug Revenue (USD Million), Gross Margin and Market Share (2019-2023)
  • Table 120. Research Programs/Design for This Report
  • Table 121. Key Data Information from Secondary Sources
  • Table 122. Key Data Information from Primary Sources
  • Table 123. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Global Botanical Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Botanical Drug Market Share by Type: 2022
  • Figure 3. Global Botanical Drug Market Share by Type: 2029
  • Figure 4. Prescription Drug Features
  • Figure 5. OTC Features
  • Figure 6. Global Botanical Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Botanical Drug Market Share by Application: 2022
  • Figure 8. Global Botanical Drug Market Share by Application: 2029
  • Figure 9. Cardiovascular Case Studies
  • Figure 10. Tumor Case Studies
  • Figure 11. Respiratory System Case Studies
  • Figure 12. Botanical Drug Report Years Considered
  • Figure 13. Global Botanical Drug Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 14. Global Botanical Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global Botanical Drug Market Share by Region: 2022
  • Figure 16. Global Botanical Drug Market Share by Region: 2029
  • Figure 17. Global Botanical Drug Market Share by Players in 2022
  • Figure 18. The Top 5 Players Market Share by Botanical Drug Revenue in 2022
  • Figure 19. The Top 10 Players Market Share by Botanical Drug Revenue in 2022
  • Figure 20. Global Botanical Drug Revenue Market Share by Type (2018-2023)
  • Figure 21. North America Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. North America Botanical Drug Market Share by Type (2018-2029)
  • Figure 23. North America Botanical Drug Market Share by Application (2018-2029)
  • Figure 24. North America Botanical Drug Market Share by Country (2018-2029)
  • Figure 25. United States Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Canada Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. Europe Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. Europe Botanical Drug Market Share by Type (2018-2029)
  • Figure 29. Europe Botanical Drug Market Share by Application (2018-2029)
  • Figure 30. Europe Botanical Drug Market Share by Country (2018-2029)
  • Figure 31. Germany Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. France Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. U.K. Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Italy Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Russia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. China Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. China Botanical Drug Market Share by Type (2018-2029)
  • Figure 38. China Botanical Drug Market Share by Application (2018-2029)
  • Figure 39. Asia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 40. Asia Botanical Drug Market Share by Type (2018-2029)
  • Figure 41. Asia Botanical Drug Market Share by Application (2018-2029)
  • Figure 42. Asia Botanical Drug Market Share by Region (2018-2029)
  • Figure 43. Japan Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. South Korea Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Southeast Asia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. India Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Australia Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America Botanical Drug Market Share by Type (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America Botanical Drug Market Share by Application (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America Botanical Drug Market Share by Country (2018-2029)
  • Figure 52. Brazil Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Mexico Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Middle East Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Africa Botanical Drug Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Bottom-up and Top-down Approaches for This Report
  • Figure 57. Data Triangulation
  • Figure 58. Key Executives Interviewed
目次

Market Analysis and Insights

The global Botanical Drug market is projected to grow from US$ 38164 million in 2023 to US$ 50499.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.78% during the forecast period.

The North America market for Botanical Drug is estimated to increase from $ 1682.4 million in 2023 to reach $ 2342 million by 2029, at a CAGR of 5.67% during the forecast period of 2024 through 2029.

The China market for Botanical Drug is estimated to increase from $ 22212 million in 2023 to reach $ 28796 million by 2029, at a CAGR of 4.42% during the forecast period of 2024 through 2029.

The Europe market for Botanical Drug is estimated to increase from $ 6650 million in 2023 to reach $ 9229 million by 2029, at a CAGR of 5.61% during the forecast period of 2024 through 2029.

The global key companies of Botanical Drug include: Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Guangzhou Baiyunshan Pharmaceutical, Tasly Holding Group, Jumpcan Pharmaceutical, Yunnan Baiyao, etc. In 2022, the global top five players had a share approximately 19.65 % in terms of revenue.

Report Includes:

This report presents an overview of global market for Botanical Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Botanical Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Botanical Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical Drugrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Botanical Drug revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, and Tasly Holding Group, etc.

By Company

  • Buchang Pharmaceuticals
  • China TCM
  • Tsumura
  • Schwabe
  • Tong Ren Tang
  • Jumpcan Pharmaceutical
  • Guangzhou Baiyunshan
  • Yunnan Baiyao
  • Tasly Holding Group
  • Bionorica Se
  • Huarun 999
  • Taiji
  • Weleda
  • Kwangdong
  • GW Pharmaceuticals

Segment by Type

  • Prescription Drug
  • OTC

Segment by Application

  • Cardiovascular
  • Tumor
  • Respiratory System
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • Middle East
    • Africa

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Botanical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Botanical Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (North America) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drugrevenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Botanical Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 Prescription Drug
    • 1.2.3 OTC
  • 1.3 Market by Application
    • 1.3.1 Global Botanical Drug Market Share by Application: 2018 VS 2022 VS 2029
    • 1.3.2 Cardiovascular
    • 1.3.3 Tumor
    • 1.3.4 Respiratory System
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Botanical Drug Market Perspective (2018-2029)
  • 2.2 Global Botanical Drug Growth Trends by Region
    • 2.2.1 Global Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Botanical Drug Historic Market Size by Region (2018-2023)
    • 2.2.3 Botanical Drug Forecasted Market Size by Region (2024-2029)
  • 2.3 Botanical Drug Market Dynamics
    • 2.3.1 Botanical Drug Industry Trends
    • 2.3.2 Botanical Drug Market Drivers
    • 2.3.3 Botanical Drug Market Challenges
    • 2.3.4 Botanical Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Botanical Drug by Players
    • 3.1.1 Global Botanical Drug Revenue by Players (2019-2023)
    • 3.1.2 Global Botanical Drug Revenue Market Share by Players (2019-2023)
  • 3.2 Global Botanical Drug Market by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Botanical Drug, Ranking by Revenue, 2021 VS 2022
  • 3.4 Global Botanical Drug Market Concentration Ratio
    • 3.4.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Botanical Drug Revenue in 2022
  • 3.5 Global Key Players of Botanical Drug Head office and Area Served
  • 3.6 Global Key Players of Botanical Drug, Founded Date
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Botanical Drug Breakdown Data by Type

  • 4.1 Global Botanical Drug Historic Market Size by Type (2018-2023)
  • 4.2 Global Botanical Drug Forecasted Market Size by Type (2024-2029)

5 Botanical Drug Breakdown Data by Application

  • 5.1 Global Botanical Drug Historic Market Size by Application (2018-2023)
  • 5.2 Global Botanical Drug Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Botanical Drug Market Size (2018-2029)
  • 6.2 North America Botanical Drug Market Size by Type
    • 6.2.1 North America Botanical Drug Market Size by Type (2018-2023)
    • 6.2.2 North America Botanical Drug Market Size by Type (2024-2029)
    • 6.2.3 North America Botanical Drug Market Share by Type (2018-2029)
  • 6.3 North America Botanical Drug Market Size by Application
    • 6.3.1 North America Botanical Drug Market Size by Application (2018-2023)
    • 6.3.2 North America Botanical Drug Market Size by Application (2024-2029)
    • 6.3.3 North America Botanical Drug Market Share by Application (2018-2029)
  • 6.4 North America Botanical Drug Market Size by Country
    • 6.4.1 North America Botanical Drug Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Botanical Drug Market Size by Country (2018-2023)
    • 6.4.3 North America Botanical Drug Market Share by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Botanical Drug Market Size (2018-2029)
  • 7.2 Europe Botanical Drug Market Size by Type
    • 7.2.1 Europe Botanical Drug Market Size by Type (2018-2023)
    • 7.2.2 Europe Botanical Drug Market Size by Type (2024-2029)
    • 7.2.3 Europe Botanical Drug Market Share by Type (2018-2029)
  • 7.3 Europe Botanical Drug Market Size by Application
    • 7.3.1 Europe Botanical Drug Market Size by Application (2018-2023)
    • 7.3.2 Europe Botanical Drug Market Size by Application (2024-2029)
    • 7.3.3 Europe Botanical Drug Market Share by Application (2018-2029)
  • 7.4 Europe Botanical Drug Market Size by Country
    • 7.4.1 Europe Botanical Drug Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Botanical Drug Market Size by Country (2018-2023)
    • 7.4.3 Europe Botanical Drug Market Size by Country (2024-2029)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia

8 China

  • 8.1 China Botanical Drug Market Size (2018-2029)
  • 8.2 China Botanical Drug Market Size by Type
    • 8.2.1 China Botanical Drug Market Size by Type (2018-2023)
    • 8.2.2 China Botanical Drug Market Size by Type (2024-2029)
    • 8.2.3 China Botanical Drug Market Share by Type (2018-2029)
  • 8.3 China Botanical Drug Market Size by Application
    • 8.3.1 China Botanical Drug Market Size by Application (2018-2023)
    • 8.3.2 China Botanical Drug Market Size by Application (2024-2029)
    • 8.3.3 China Botanical Drug Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Botanical Drug Market Size (2018-2029)
  • 9.2 Asia Botanical Drug Market Size by Type
    • 9.2.1 Asia Botanical Drug Market Size by Type (2018-2023)
    • 9.2.2 Asia Botanical Drug Market Size by Type (2024-2029)
    • 9.2.3 Asia Botanical Drug Market Share by Type (2018-2029)
  • 9.3 Asia Botanical Drug Market Size by Application
    • 9.3.1 Asia Botanical Drug Market Size by Application (2018-2023)
    • 9.3.2 Asia Botanical Drug Market Size by Application (2024-2029)
    • 9.3.3 Asia Botanical Drug Market Share by Application (2018-2029)
  • 9.4 Asia Botanical Drug Market Size by Region
    • 9.4.1 Asia Botanical Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Botanical Drug Market Size by Region (2018-2023)
    • 9.4.3 Asia Botanical Drug Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Botanical Drug Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Botanical Drug Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Botanical Drug Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Botanical Drug Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Botanical Drug Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Botanical Drug Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Botanical Drug Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Botanical Drug Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Botanical Drug Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Botanical Drug Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Middle East
    • 10.4.7 Africa

11 Key Players Profiles

  • 11.1 Buchang Pharmaceuticals
    • 11.1.1 Buchang Pharmaceuticals Details
    • 11.1.2 Buchang Pharmaceuticals Major Business Analysis
    • 11.1.3 Buchang Pharmaceuticals Botanical Drug Product and Solutions
    • 11.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.2 China TCM
    • 11.2.1 China TCM Details
    • 11.2.2 China TCM Major Business Analysis
    • 11.2.3 China TCM Botanical Drug Product and Solutions
    • 11.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.3 Tsumura
    • 11.3.1 Tsumura Details
    • 11.3.2 Tsumura Major Business Analysis
    • 11.3.3 Tsumura Botanical Drug Product and Solutions
    • 11.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.4 Schwabe
    • 11.4.1 Schwabe Details
    • 11.4.2 Schwabe Major Business Analysis
    • 11.4.3 Schwabe Botanical Drug Product and Solutions
    • 11.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.5 Tong Ren Tang
    • 11.5.1 Tong Ren Tang Details
    • 11.5.2 Tong Ren Tang Major Business Analysis
    • 11.5.3 Tong Ren Tang Botanical Drug Product and Solutions
    • 11.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.6 Jumpcan Pharmaceutical
    • 11.6.1 Jumpcan Pharmaceutical Details
    • 11.6.2 Jumpcan Pharmaceutical Major Business Analysis
    • 11.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Solutions
    • 11.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.7 Guangzhou Baiyunshan Pharmaceutical
    • 11.7.1 Guangzhou Baiyunshan Pharmaceutical Details
    • 11.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business Analysis
    • 11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Solutions
    • 11.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.8 Yunnan Baiyao
    • 11.8.1 Yunnan Baiyao Details
    • 11.8.2 Yunnan Baiyao Major Business Analysis
    • 11.8.3 Yunnan Baiyao Botanical Drug Product and Solutions
    • 11.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.9 Tasly Holding Group
    • 11.9.1 Tasly Holding Group Details
    • 11.9.2 Tasly Holding Group Major Business Analysis
    • 11.9.3 Tasly Holding Group Botanical Drug Product and Solutions
    • 11.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.10 Bionorica Se
    • 11.10.1 Bionorica Se Details
    • 11.10.2 Bionorica Se Major Business Analysis
    • 11.10.3 Bionorica Se Botanical Drug Product and Solutions
    • 11.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.11 Huarun 999
    • 11.11.1 Huarun 999 Details
    • 11.11.2 Huarun 999 Major Business Analysis
    • 11.11.3 Huarun 999 Botanical Drug Product and Solutions
    • 11.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.12 Taiji
    • 11.12.1 Taiji Details
    • 11.12.2 Taiji Major Business Analysis
    • 11.12.3 Taiji Botanical Drug Product and Solutions
    • 11.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.13 Weleda
    • 11.13.1 Weleda Details
    • 11.13.2 Weleda Major Business Analysis
    • 11.13.3 Weleda Botanical Drug Product and Solutions
    • 11.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.14 Kwangdong
    • 11.14.1 Kwangdong Details
    • 11.14.2 Kwangdong Major Business Analysis
    • 11.14.3 Kwangdong Botanical Drug Product and Solutions
    • 11.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)
  • 11.15 GW Pharmaceuticals
    • 11.15.1 GW Pharmaceuticals Details
    • 11.15.2 GW Pharmaceuticals Major Business Analysis
    • 11.15.3 GW Pharmaceuticals Botanical Drug Product and Solutions
    • 11.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2019-2023)

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer